Inside Science – BBC Radio 4
One of our members thought that others would find this Inside Science broadcast on Radio 4 interesting.
Inside Science – BBC Radio 4 Read More »
About MS
One of our members thought that others would find this Inside Science broadcast on Radio 4 interesting.
Inside Science – BBC Radio 4 Read More »
Since 8th June 2019, Steve Barnes, who regularly attends the Berkshire MS Therapy Centre, has been travelling to Canterbury each week to be involved in the medical trial using a robotic suit to exercise:
My Robot story by Steve Barnes. Read More »
Source MS Trust: Action potential simulation is a complementary therapy which some people use as a treatment for pain in MS. It’s available at some MS Therapy Centres in the UK. (Note: We offer this at BMSTC, find out more about our service here.)
Have you heard of action potential simulation (APS) therapy? Read More »
Source Neurology Advisor: For patients with progressive multiple sclerosis, a diet-induced lipid profile change improved fatigue, according to a study published in PLoS One.
Changes in Lipid Profile Affect Fatigue in Progressive Multiple Sclerosis Read More »
Source MS Trust: People with neurological conditions are facing long waiting times, limited access to specialists, poor mental health support and a failing social care system, according to a new survey by The Neurological Alliance.
Source MS Trust: Finding the right holiday for you.
Top tips for a stress-free summer holiday Read More »
Led by the University of Plymouth and published today in The Lancet Neurology, the study in people with progressive MS also showed that the intervention appeared cost-effective, leading researchers to conclude that it could be routinely implemented within MS care throughout the UK.
Source UCLH.nhs.uk: UCLH’s Biomedical Research Centre has supported the development of a new artificial intelligence-based method for detecting the brain’s response to treatment in multiple sclerosis (MS) that is substantially better than what a human expert is able to do using conventional techniques, representing potentially ‘superhuman’ performance in the task.
Researchers devise AI-based method of detecting response to MS Read More »
Source Science Daily: Researchers have found mutations in 12 genes believed to be largely responsible for the onset of multiple sclerosis in families with multiple members diagnosed with the disease.
Scientists edge closer to root causes of multiple sclerosis Read More »
Source MS Trust: The MS Trust is delighted that Ocrevus (ocrelizumab) has been approved by NICE for NHS treatment of early, inflammatory primary progressive MS.
Good news! NICE approves Ocrevus (ocrelizumab) for primary progressive MS Read More »